ArgusEye

ArgusEye is a private, commercial-stage diagnostics and digital health company providing a hardware and consumables platform for real-time bioprocess analytics. Its patented Auga™ platform, centered on LSPR biosensor technology, offers continuous monitoring of targets like antibodies and aggregates directly in the process stream, aligning with Process Analytical Technology (PAT) initiatives. The company's solutions are designed to reduce development time and costs for biologics manufacturers, a value proposition recently bolstered by a significant €6.25 million grant from the European Innovation Council (EIC) Accelerator. ArgusEye operates in the high-growth bioprocess analytical instrumentation market, competing on the specificity and real-time capability of its label-free sensing technology.

Patented Auga™ platform utilizing Localized Surface Plasmon Resonance (LSPR) biosensor technology for real-time, label-free, in-line and on-line monitoring of biomolecules in bioprocess streams.

ArgusEye competes in the bioprocess analytical instrumentation market against large players like Sartorius (with its BioPAT® suite), Cytiva, and Thermo Fisher Scientific, which offer various spectroscopy and sensor technologies. Its differentiation lies in the specific application of LSPR for continuous, label-free protein monitoring, competing with niche players and other emerging sensor startups.